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Abstract
Background: The bovine spongiform encephalopathy (BSE) epidemic presented homogeneity of the phenotype. This 
classical BSE (called C-type) was probably due to the contamination of the food chain by a single prion strain. However, 
due to the active surveillance and better techniques, two rare variants of BSE have been recently reported in different 
continents without a clear correlation to the BSE epidemic. These emerging types behave as different strains of BSE and 
were named H-type and L-type according to the high and low molecular mass of the unglycosylated fragment of their 
proteinase K resistant prion protein (PrPres). In these types, the proportion of the un-, mono- and di-glycosylated 
fragments of PrP (glycoprofile) is also atypical and represents an effective diagnostic parameter. This study evaluated 
the presence of such types in bovine of 7 years and older in Belgium.
Results: The Belgian BSE archive contained 41 bovines of at least 7 years of age. The biochemical features of their PrPres 
were analyzed by Western blot with five antibodies recognising different regions of PrPres, from N- to C-terminus: 12B2, 
9A2, Sha31, SAF84 and 94B4. All antibodies clearly detected PrPres except 12B2 antibody, which is specific for N-terminal 
region 101-105, a PrP region that is only retained in H-types. The glycoprofiles did correspond to that of C-type (with 
more than 55% of diglycosylated PrPres using antibody 94B4). Therefore, all cases have the features of C-type BSE.
Conclusions: This study supports that, among the BSE cases of 7 years and older identified in Belgium, none was 
apparently of the H- or L- type. This is consistent with the very rare occurrence of atypical BSE and the restricted 
dimension of Belgium. These results shed some light on the worldwide prevalence of atypical BSE.
Background
Prion diseases are infectious neurodegenerative diseases
with slow development and lethal outcome. The active
agents in this disease family are called prions. Prion dis-
eases are unique as a normal host cellular protein, prion
protein (PrPc), is usually affected by conformational
change and aggregation which leads to the accumulation
of PrPd (associated to the disease), usually in the nervous
system [1]. There is indeed no specific nucleic acid
involved [2]. PrPd is partly resistant to digestion by pro-
teases and the resultant product of such digestion (PrPres)
is used in diagnostic applications as a highly reliable dis-
ease marker [3,4]. Usually, the brain shows microscopic
symmetrical spongiosis. Prion diseases are therefore also
called transmissible spongiform encephalopathies (TSE).
These diseases in animals are mainly transmitted by the
dietary route and already described for centuries in sheep
as scrapie. Other examples of TSE are chronic wasting
disease in deer and elk (CWD), Creutzfeldt-Jakob disease
in humans (CJD), transmissible mink encephalopathy and
bovine spongiform encephalopathy (BSE), also known as
mad cow disease. Evidence for transmission of BSE was
found in various other mammals including humans,
where it causes a form of CJD - variant CJD (vCJD) -
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Page 2 of 9which affects especially young persons and exhibits
unique molecular and histological features [5-8].
While in scrapie and other TSEs strain variations were
found, BSE initially showed strain homogeneity [9-12].
Indeed, incubation time, vacuolar lesion profile and bio-
chemical signature of PrPd were identical for all investi-
gated cases. This uniform aspect of the BSE prions during
the epidemic was probably due to the contamination of
the food chain by a single strain in United Kingdom [13].
However, due to the extensive active surveillance and
new research techniques, rare variants of BSE have been
reported since 2003 [14-24] of which most could be clas-
sified in two new types of BSE: H- and L-type [20]. The
analysis of their features in bioassay showed that these
emerging types represent different strains of BSE [25-28].
Two well identified atypical forms of BSE have been
described. Western blot studies showed that, in compari-
son to classical BSE (C-type), they are characterised by a
higher or lower molecular mass of the unglycosylated
PrPres and were thus named H-type and L-type BSE [20].
L-type is also called bovine amyloid spongiform enceph-
alopathy or BASE. The PrPres glycoprofile is a very practi-
cal marker for the L-type, which shows a much lower
proportion of diglycosylated PrPres (<50% of total PrPres)
than C-type (>55% of total PrPres). For H-type, a relatively
high reactivity with antibody 12B2 is archetypal because
of the characteristic presence of its epitope at the N-ter-
minal end of PrPres. A second characteristic of H-type
involves a dualistic glycoprofile depending on the anti-
body used. As the brain area of the PrPres deposition can
differ drastically between the L- and C-type [16,29] and
potentially also between H- and C-type, it would be bet-
ter if the sampling techniques presently used are adapted
to these atypical types.
Such types are very rare; only 42 cases were described
worldwide and these were all detected in old bovines (at
least eight years in age) [19-22,30], except one case from a
23 month old cow that could not be further investigated
in depth due to shortage of sample [14]. They were
reported on different continents. Indeed they might cor-
respond to natural "sporadic" forms of BSE, not originat-
ing from the contamination of the food chain [31]. In the
past, a 60 month old unclassified BSE case was described
in Belgium when molecular typing techniques and com-
parison with L- and H-types was not available [17]. This
sample was re-examined with the current techniques in
the present study. It is essential for the surveillance pro-
grammes to determine the prevalence on a global level of
these atypical types. Therefore this study retrospectively
analysed the bovines of at least 7-years-old in the Belgian
archive of BSE-diagnosed cattle, using the latter criteria
and techniques, in order to determine whether these
types of atypical BSE were present in old BSE-positive
bovines in Belgium.
Results
Firstly the H-, L- and C-type reference samples were
investigated. In the H-type sample, the unglycosylated
band migrated at a higher gel position than in the C-type;
moreover the H-type reacted strongly to 12B2 contrary to
C- and L-type. It showed a dualistic glycoprofile between
group B antibody Sha31 and group C antibody SAF84
(Fig. 1). Furthermore, H-type BSE showed a fourth band
of low molecular mass when antibody SAF84 was applied
(Fig. 1, arrow). In addition of the absence of 12B2 reactiv-
ity as mentioned above, the analysed L-type showed simi-
lar glycoprofile with group B and C antibody, with a high
proportion of monoglycosylated band (four replicates
with Sha31: 38.9%, SD = 3.6 vs. 17.3%, SD = 4.9 for C-
type, Fig. 1).
The analyses of the Belgian BSE archive did not yield
any atypical case. As an illustration, blots obtained with
the five different antibodies for seven given samples are
presented in Fig. 2. In this figure, PrPres was clearly
detected with group B and C antibodies. As it is typical
for C-type and L-type BSE, the 12B2 N-terminal epitope
is largely removed by proteinase K in all analyzed samples
and this is most evident when comparing the signals of
12B2 with those of Sha31.
The apparent molecular mass (Mr) obtained for the 39
samples with Sha31 can be found in Fig. 3. The observed
molecular masses display a great variability which can be
ascribed to the inaccurate capacity of SDS-PAGE for a
reliable estimation of the small Mr differences between
the unglycosylated PrPres bands of different samples even
if measured in triplicate or more. As main evidence for
discrimination, the group A antibody 12B2 hardly bound
compared to group B antibody Sha31, and the glycopro-
files of all the samples exhibited a typical C-type glyco-
profile with group B and group C antibodies with >55%
diglycosylated PrPres band. To further exemplify this, the
glycoprofiles of the individual samples as probed with
antibody 94B4 have been plotted in Fig. 4 and compared
with the L-type and H-type results. In this last figure, it is
clear that the glycoprofiles of the samples did correspond
to that of C-type, as characterized by a fraction of digly-
cosylated PrPres of 55% or more using group C antibody
(94B4); the L-type and H-type showed diglycosylated
fractions below 50%. Therefore, all cases of age 7 years
and older have the features of C-type BSE. The discrimi-
nation is easier than in a previous report [20]; this can be
due to a better resolution of the blots and thus a more
accurate estimation linked to the use of an imager in the
present study instead of photographic film plus subse-
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C antibody (SAF 84) also allowed a straightforward dis-
crimination, a group B antibody (Sha31) did not (see both
H-type profiles in Fig. 4). Thus, depending on the anti-
body used, the H-type sample exhibited a different glyco-
profile (dualistic glycoprofile).
A previously reported 5-year old case demonstrated a
fast migration of the unglycosylated band at the time [17].
However, reinvestigation of available little left-over mate-
rial with the current improved tools and knowledge lead
to the conclusion that this case does belong to the C-type
category (see additional file 1: Blots of published sample).
Discussion
This study supports that, among the BSE cases of 7 years
and older identified in Belgium, none was apparently of
the H- or L- type. Unfortunately, three aged BSE cases
have not been investigated due to insufficient availability
of positive tissue. Nevertheless, as atypical BSE remains
very rare, our results are not incongruous. Our previously
reported case from [17] reinvestigated with the current
improved tools lead to the conclusion that this case does
belong to the C-type category.
The results shed some light on the worldwide preva-
lence of atypical BSE. The absence of atypical cases can
be linked to the limited sample size due to the dimension
of Belgium, and is also likely to occur when comparing
the variable prevalences found in other countries like
France (8 L-types, 8 H-types), Poland (6 L-types, 1 H-
type), Italy (3 L-types), The Netherlands (2 L-types, 1 H-
type), Germany (1 L-type, 1 H-type), United Kingdom (2
H-types), Switzerland (1 H-type) and Catalunya, Spain
(none) [20,32]. In all these countries, all cattle of 7 years
and older have been tested post-mortem for the presence
of BSE using sensitive screening methods. An extensive
study already estimated the frequency of H-type and L-
type BSE in France to 1.9 and 1.7 per million cattle more
than eight years of age [31]. This corresponds to 0.41 and
0.35 atypical cases per million of tested cattle. With
almost three million cattle tested in Belgium since 1997,
one could have expected to find roughly one H-type and
one L-type (i.e. 1 atypical case every five years). It is also
possible though difficult to prove, that atypical cases have
been missed during the routine surveillance programme
due to 1) an unusual location of the PrPres deposition in
the brain since at least L-types have a preferential distri-
bution of PrPres in the forebrain region [16] and active
surveillance methods are based on the brainstem; and 2)
a susceptibility of critical epitopes of PrPres in L- and/or
H-type cases to proteinase treatment used for detection
combined with the method (TeSeE ELISA of Bio-Rad)
used for initial screening (which is dependant on pre-
Figure 1 Western blots comparing C-, L- and H-types. Western 
blots comparing reference samples of L-, C- and experimental H-type 
isolates (indicated by L, C and H). From top to bottom, the three bands 
of each sample correspond to di-, mono- and unglycosylated forms of 
the PrP. The different reaction of C-type in comparison to H-type is vis-
ible with 12B2 antibody (a), the higher molecular mass of H-type is re-
vealed by Sha31 antibody (b) and the presence of a fourth band in H-
type is shown by SAF84 antibody (c, arrow). L-type shows a greater 
proportion of monoglycosylated band compared to the diglycosylat-
ed band with Sha31 antibody than C-type. A molecular marker kit is 
displayed (MM, three arrow heads represent position of Mr 20, 30 and 
40 kDa). The antibody concentrations used were 2 μg/ml for 12B2 and 
SAF84. For Sha31, the manufacturer's instructions were followed. The 
applied tissue equivalents are 7.1 mg of fresh brain per lane. The expo-
sure time in the imager was 5 min.
(b)
MM L C H
(c)
MM L C H
(a)
MM L C H
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Figure 2 Differences between the five antibodies used. Blots showing six bovine C-type BSE samples (a to f) analysed by five antibodies. Two mo-
lecular marker kits are each applied twice (lanes 1, 5, 9, and 10; arrow heads indicate for M1: positions of 20 and 25 kDa; and for M2: 20, 30 and 40 kDa). 
The groups to which the antibodies belong are shown at the right and have been defined in [30]. Group A antibodies recognise a region of the protein 
close to the N-terminus, group B recognises the core of the protein while group C antibodies bind in the C-terminal region of PrP. Antibody concen-
trations were 2, 0.5, 2 and 0.5 μg/ml for 12B2, 9A2, SAF84 and 94B4 respectively, and for Sha31 the manufacturer's instructions were followed. SDS-
PAGE gels were 15%, except for Sha31, which was 13.5%. Tissue equivalents applied were 7.1 mg of fresh brain per lane. The strongly positive BSE 
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Page 5 of 9cious protection of an N-terminally located epitope for
capturing PrPres). With respect to the latter point, screen-
ing tests have been developed using C-type cases which
appear to be more resistant to digestion with proteinase
K than H- and L-type cases [20]. However, it must be
mentioned that a significant proportion of L- and H-type
cases were detected using this type of capture ELISA [20],
the most frequently test used up till 2007. This issue of
suitability of screening tests needs nevertheless more
attention in future studies when sufficient material is
available e.g. from experimentally infected animals.
The age of tested cohort is a determining factor. For
example, the cattle population in Poland is older than in
other European countries and this country presents high
atypical-BSE prevalence (especially of L-types) [21].
However this does not fully explain the prevalence of
atypical BSE, as The Netherlands have a higher preva-
lence with an age structure of bovine population similar
to that of Belgium. For now, the importance of the spon-
taneous aspect of (atypical) BSE remains an open ques-
tion.
The frequencies of atypical BSE cases are similar to
those of the human sporadic Creutzfeldt-Jakob disease
(sCJD). Indeed atypical cases were detected in BSE-
exposed countries (France, Italy, Germany, The Nether-
lands, etc. [20]) as well as in a low BSE-exposed country
(Sweden [22]). This reinforces the hypothesis of a spo-
radic origin of atypical BSE [30]. These atypical BSE cases
might have existed previously and by their very low fre-
quency remained undetectable for veterinarians, until the
introduction of the active surveillance programmes and
improvements of diagnostic tools
The origin of the current BSE epidemic could be linked
to atypical BSE, especially in view of the properties of L-
type (or BASE) [26,27]. It is however also not excluded
that the real source of the epidemic was derived from C-
type case (which might also have a spontaneous origin),
and thus that such cases have always existed sporadically.
In such situation when continuing surveillance, C-type
cases will be detected in older animals at a stable sporadic
level. Potentially brain stem might not be the first site for
PrPres development.
About the typing technique used, it is important to
note that the apparent molecular mass differences can be
useful but present as rather imprecise and impractical
criteria for molecular typing of PrPres (Fig. 3). The H-
Figure 3 Apparent molecular masses of the analysed PrPres. Average apparent molecular masses PrPres in the 39 Belgian BSE cases as tested with 
Sha31 antibody. The values of the three forms are displayed (un-, mono- and diglycosylated forms). The values for H-type (H, darker symbols), C-type 
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Page 6 of 9types can be discriminated with that measure if com-
pared with C-types (Fig. 1a). However, given the preci-
sion of the Western blot technique, the differences in
apparent molecular mass of PrPres for L-types are too
small to be undoubtedly detected (0.3 and 0.8 kDa)
[18,33]. Other properties yield a more robust approach.
For example, the affinity to PrPres to the antibodies from
different groups makes H-types easily detectable. Group
A antibodies like 12B2 are in comparison to group B anti-
bodies highly reactive due to the N-terminal epitope
present, and group C antibodies like SAF84 and 94B4 rec-
ognize a fourth band (positioned at about 10-12 kDa).
This band corresponds to the unglycosylated moiety of a
second population of PrPres triplet. This feature is unique
for H-type and thus a fundamental characteristic of this
strain [20]. It is not known if this phenomenon occurs in
vivo or is a by-product of proteinase K treatment. A pow-
erful discrimination tool remains the comparison of gly-
coprofiles, i.e. the proportions of the three forms of the
PrP. L-types and C-types differ by their proportion of dig-
lycosyl-PrPres which is respectively at/below and above
50% of total PrPres. These proportions remain visible
whether detection is performed with group B or C anti-
bodies. However, H-types have a dualistic glycoprofile
with high proportion of diglycosyl moiety when tested
with group A and B antibodies and high proportion of
monoglycosyl-PrP when tested with group C antibodies
(Fig. 4). In H-types the dualistic phenomenon is linked to
the presence of a second PrP population with a very short
C-terminal region detected only by C-terminus specific
antibodies. The three PrPres moieties of this second popu-
lation (PrPres-2) are 5-10 kDa smaller in molecular mass
than those of the first population (PrPres-1) and are only
detectable by group C antibodies like SAF84 and 94B4.
Consequently the migration position of diglycosylated
band in PrPres-2 coincides with that of the monoglycosy-
lated band of population PrPres-1 [20,30].
The emergence of atypical types of BSE is due to the
active surveillance screening, a better awareness of prion
strain variations, and more efficient diagnostic tech-
niques. However considering molecular properties, PrPres
in atypical cases is more susceptible to proteinase K treat-
ment and the area in the brain where PrPres is deposited
differs at least between C- and L-types. It is therefore
essential to ascertain that the routine sampling and ana-
lytical techniques are adapted to these new types. As
these new strains seem more virulent than classical types,
at least in mice models [27,34-36], they represent one of
the next challenges in the field of prions.
Conclusions
This analysis of the old bovines in the Belgian archive did
not show any atypical BSE case in these cohorts. The
study implied 42 bovines of at least 7 years of age. Even
with the restricted size of Belgium, one could have
expected a few atypical cases (as observed in The Nether-
lands). This difference can be random or linked to an
unknown particularity of our samples. Anyway, the




From the Belgian archive of the 133 BSE-positive bovines,
the animals of 7 years and older were selected (N = 41, see
Table 1). In Belgium, until 2007, all BSE surveillance labo-
ratories used the Biorad TeSeE ELISA kit for BSE case
detection. Based on the availability of remnant suitable
brain material, 38 bovines could be analysed; they were
aged 93 months old in median (min: 84, max: 181
months). They were detected from August 1999 up till
October 2006, when the last BSE case in Belgium was
found. The median detection date was November 2002.
Among the 41 cattle, ten were 8 years old and ten were 9
years or older. We also added to the present analysis the
bovine having shown unusual features in a previous anal-
ysis [17]. This animal was 64 months old.
Tissue analyses
First the approximate PrPres concentration in brain
homogenates was estimated by an ELISA test (Bio-Rad:
Figure 4 Glycoprofiles of the analysed PrPres. Glycoprofiles of the 
39 resistant prion proteins (PrPres), obtained with antibody 94B4. The 
PrP possesses two, one or no carbohydrates attached. These three 
forms are found in various proportions in a given animal. Colours refer 
to the percentage of the diglycosylated form. The average glycopro-
files (with standard deviations) obtained with 94B4 for a reference iso-
late of H-type and L-type are indicated (HC and L, showing lower 
diglycosylated percentage, <50% for L-type, 3 replicates). HB repre-
sents the H-type glycoprofile using a group B antibody (Sha31), not al-
lowing a clear discrimination. The three-arrow symbol is to assist the 
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Page 7 of 9TeSeE, ref 355 1144 and 355 1194) following the manu-
facturer's instructions. This TeSeE ELISA carried out on
the samples confirmed all of them as positive. The
median optical density was 14 times higher than the cut-
off (minimum: 1.48). Only three samples were slightly
close to the cut-off (1.48 to 2.30 times the cut-off ).
Then the study was carried out with a Western blot
test-kit (Bio-Rad: Bovine WB, ref 355 1169) modified
with a panel of PrP specific antibodies. The antibodies
used, namely 12B2, 9A2, Sha31, SAF84, 94B4 are known
to detect different regions of the PrP. These antibodies
are classified in three groups following a previous cate-
gorisation [30] from N- to C-terminal PrP epitope speci-
ficity: group A (12B2) to region ± 86-108, B (9A2, Sha31)
to region ± 108-157 and C (SAF84 and 94B4) to region ±
157-242. The use of these antibodies allows an efficient
typing diagnostic.
Briefly, 250 μl of 20% homogenates were incubated with
250 μl of proteinase K solution at 37°C for 10 min. After
the addition of 250 ml of reagent B, the samples were cen-
trifuged at 15000 g for 7 min. The pellets were resus-
pended by incubating them during 5 min in 100 μl of
Laemmli loading buffer [37]. The pellet was dissolved by
pipetting and scratching with the tip. Then the samples
were heated at 100°C for 5 min. After vortexing, the sam-
ples were centrifuged at 15000 g for 15 min. Then 15 μl of
the supernatants, heated at 100°C, were run on a 13.5 or
15% sodium dodecyl sulphate polyacrylamide gel accord-
ing to Laemmli [37] (Fig. 1). The proteins were then
transferred on nitrocellulose membranes. The mem-
branes were blocked by 5% non-fat dry milk (1 h, for 12B2
and SAF84), by 3% serum albumine bovine (1 h, for 9A2
and 94B4) or by kit blocking solution (30 min, for Sha31).
The membranes were then incubated with the antibodies
for 30 min. After three washes in PBS-Tween, the mem-
branes were incubated for 20 min for most antibodies
with a mixture of horseradish-peroxidase-labelled conju-
gate (for antibody detection: goat anti-mouse Ig(H+L),
Clinisciences 1010-05, Montrouge, France) and streptavi-
din-peroxidase (for molecular mass marker detection).
Sha31 was detected using the kit conjugate. After four
washes in PBS-Tween and one in PBS, the bound anti-
bodies were detected with chemoluminescence (Super-
Signal West Dura, Pierce) in Versadoc (Bio-Rad). The
PrPres signals were analysed with an image-analysis soft-
ware (Quantity One, Bio-Rad). The apparent molecular
mass was determined using two molecular mass marker
kits (Magic Mark, Invitrogen and Precision Plus Protein
Kaleidoscope, Bio-Rad). The tissue equivalent applied per
lane was 7.1 mg of fresh brain.
As a primary validation, the method used in this study
was controlled by comparing known C-types to an exper-
imental H-type generated at CVI-WUR, Lelystad, The
Netherlands and an L-type diagnosed in Poland [21]
(kindly provided by Miroslaw Polak). Our intended analy-
sis was based on the most crucial characteristics for a
correct typing of PrPres: firstly the apparent molecular
mass of the un-, mono- and diglycosylated bands (higher
in H-types, lower in L-types) using group B antibody, sec-
ondly the binding behaviour of the antibodies for PrPres
compared to that of antibody Sha31 (e.g. 12B2 reacts only
well with PrPres of H-types, SAF84 detects a fourth band
in H-types), and thirdly the glycoprofile based on the rel-
ative proportions of the visible bands (a lower diglycosy-
lated proportion is characteristic for L- and H- type BSE
with group C antibodies used, compared to C-type BSE
samples), and fourthly, only H-type samples shows two
glycoprofiles depending on the antibody used (group A
and B antibodies show a C-type glycoprofile, while group
C antibodies have a unique glycoprofile); this two-glyco-
profile character of H-types was defined as a dualistic gly-
coprofile behaviour [20]. Alternatively said, a sample is
considered as H-type if it shows three clear bands with
12B2 antibody and a fourth band with SAF84 antibody at
10-12 kDa. For L-types, the decisive discrimination crite-
rion was the absence of significant reactivity with group
A antibody (12B2) and a glycoprofile of <50% of diglyco-
sylated and ≥ 30% monoglycosylated PrPres with use of
Table 1: Distribution of the 41 bovines according to their age (in years)
Age 7-7.4 7.5-7.9 8-8.4 8.5-8.9 9-9.4 9.5-9.9
Total 9 13 7 3 3 0
Age 10-10.4 10.5-10.9 11-11.4 11.5-11.9 12-12.4 15-15.4
Total 3 1 0 0 2 1
* indicate the three unanalysed samples. Due to absence of cases, five empty cohorts before the last one are not indicated. The 64-months-
old bovine analysed in 2004 is not included.
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